Exploring novel modified vitamin B12 as a drug carrier: forecast from density functional theory modeling

J Phys Chem B. 2013 Aug 22;117(33):9655-61. doi: 10.1021/jp405821k. Epub 2013 Aug 9.

Abstract

Three non-native derivatives of vitamin B12 with imidazole, ethylenediamine, and pyrazine as cobalt(III) β-ligands were characterized by applying the BP/def2-TZVP density functional method. The binding of all three ligands is thermodynamically favorable. It is proposed that their synthesis might be possible from aquacobalamin as a starting form of vitamin B12, as has been done in the case of an imidazole derivative of B12 (Hannibal et al. Inorg. Chem. 2007, 46, 3613-3618). Furthermore, the possibility of the formation of their conjugates with cisplatin is investigated. The proposed β-ligands may serve as bridging ligands, binding to the platin ion as N-donors. In parallel, the calculations are done for the previously synthetized B12-cisplatin adduct with CN(-) as a bridging ligand and are compared with available experimental data, allowing assessment of the applied computational protocol. A good agreement between the computed and experimental structural parameters is obtained. In each of the studied structures, the Co-β-ligand bond is weaker than the Pt-β-ligand bond.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cisplatin / chemistry
  • Cobalt / chemistry
  • Coordination Complexes / chemistry
  • Drug Carriers / chemistry*
  • Ethylenediamines / chemistry
  • Imidazoles / chemistry
  • Ligands
  • Models, Theoretical*
  • Pyrazines / chemistry
  • Vitamin B 12 / analogs & derivatives
  • Vitamin B 12 / chemistry*

Substances

  • Coordination Complexes
  • Drug Carriers
  • Ethylenediamines
  • Imidazoles
  • Ligands
  • Pyrazines
  • aquacobalamin
  • Cobalt
  • ethylenediamine
  • imidazole
  • Vitamin B 12
  • Cisplatin